Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00770900Phase 4Completed
Phase 4, randomised, double-blind trial in asthma comparing Montelukast with Placebo (2 arms). Primary endpoint: Quantitative parameters of eosinophil activation and phagocyte system function at 12 weeks. Started Sep 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00770900.